Bcl2, a transcriptional target of p38α, is critical for neuronal commitment of mouse embryonic stem cells

Cell Death and Differentiation

Volumn 15, Issue 9, 2008, Pages 1450-1459

  Trouillas, M ^a,b,c   Saucourt, C ^a,b,c   Duval, D ^d,e   Gauthereau, X ^a,b,c   Thibault, C ^d   Dembele, D ^d   Feraud, O ^f   Menager, J ^f   Rallu, M ^f   Pradier, L ^f   Boeuf, H ^a,b,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CNRS   (France)

^c IFR 66   (France)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITÉ DE PERPIGNAN   (France)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD24 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; INHIBITOR OF DIFFERENTIATION 2; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN BCL 2; PROTEIN NODAL; PROTEIN P38ALPHA; RETINOIC ACID; SYNAPTOPHYSIN;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; GENE CONTROL; GENE IDENTIFICATION; GENE REPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 49949092759     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.63     Document Type: Article

References (50)

1. Shellard J, Perreau J, Brulet P. Role of leukemia inhibitory factor during mammalian development. Eur Cytokine Netw 1996; 7: 699-712.
2. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002; 12: 432.
3. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 2003; 21: 5-14.
4. Babinet C, Cohen-Tannoudji M. Genome engineering via homologous recombination in mouse embryonic stem (ES) cells: An amazingly versatile tool for the study of mammalian biology. An Acad Bras Cienc 2001: 73: 365-383.
5. Smith AG. Embryo-derived stem cells: Of mice and men. Annu Rev Cell Dev Biol 2001; 17: 435-462.
6. Wobus AM, Boheler KR. Embryonic stem cells: Prospects for developmental biology and cell therapy. Physiol Rev 2005; 85: 635-678.
7. Duval D, Reinhardt B, Kedinger C, Boeuf H. Role of suppressors of cytokine signaling (Socs) in leukemia inihibitory factor (LIF) -dependent embryonic stem cell survival. FASEB J 2000; 14: 1577-15884.
8. Duval D, Malaise M, Reinhardt B, Kedinger C, Boeuf HA. p38 inhibitor allows to dissociate differentiation and apoptotic processes triggered upon LIF withdrawal in mouse embryonic stem cells. Cell Death Differ 2004; 11: 331-341.
9. Duval D, Trouillas M, Thibault C, Dembele D, Diemunsch F, Reinhardt B et al. Apoptosis and differentiation commitment: Novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death Differ 2006; 13: 564-575.
10. Li M. Pevny L. Lovell-Badge R. Smith A. Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol 1998; 8: 971-974.
11. Ying QL, Smith AG. Defined conditions for neural commitment and differentiation. Methods Enzymol 2003; 365: 327-341.
12. Bouhon IA, Kato H. Chandran S, Allen ND. Neural differentiation of mouse embryonic stem cells in chemically defined medium. Brain Res Bull 2005; 68: 62-75.
13. Gossrau G, Thiele J, Konang R, Schmandt T, Brustle O. Bone morphogenetic protein-mediated modulation of lineage diversification during neural differentiation of embryonic stem cells. Stem Cells 2007; 25 939-949.
14. Aouadi M, Bost F, Caron L, Laurent K, Le Marchand Brustel Y, Binetruy B. p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis. Stem Cells 2006; 24: 1399-1406.
15. Keren A. Tamir Y, Bengal E. The p38 MAPK signaling pathway: A major regulator of skeletal muscle development. Mol Cell Endocrinol 2006; 252: 224-230.
16. Binetruy B, Heasley L, Bost F, Caron L, Aouadi M. Concise review: regulation of embryonic stem cell lineage commitment, by mitogen-activated protein kinases. Stem Cells 2007; 25: 1090-1095.
17. Kumar S, Boehm J, Lee JC. p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003; 2: 717-726.
18. Abraham RT. MAPKAP kinase-2; three's company at the G(2) checkpoint. Mol Cell 2005; 17: 163-164.
19. Horstmann S, Kahle PJ, Borasio GD. Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro. J Neurosci Res 1998; 52: 483-490.
20. Hensley K, Floyd RA, Zheng NY, Neel R, Robinson KA, Nguyen X et al p38 kinase is activated in the Alzheimer's disease brain. J Neurochem 1999; 72: 2053-2058.
21. Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE et al MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem 2006; 281: 23658-23667.
22. Niu W, Huang C, Nawaz Z, Levy M, Somwar R, Li D et al. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. J Biol Chem 2003; 278: 17953-17962.
23. Pfeiffer ZA, Aga M, Prabhu U, Watters JJ, Hall DJ, Bertics PJ. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho. J Leukoc Biol 2004; 75: 1173-1182.
24. Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R. Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 2004; 4: 6539-6549.
25. Lee ER, McCool KW, Murdoch FE, Fritsch MK. Dynamic changes in histone H3 phosphoacetylation during early embryonic stem cell differentiation are directly mediated by mitogen- and stress-activated protein kinase 1 via activation of MAPK pathways. J Biol Chem 2006; 281: 21162-21172.
26. Saklatvala J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 2004; 4: 372-377.
27. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Deficiency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells. J Exp Med 2000; 191: 859-870.
28. Ihle JN. The challenges at translating knockout phenotypes into gene function. Cell 2000; 102: 131-134.
29. Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F. Role of MAPKs in development and differentiation: Lessons from knockout mice. Biochimie 2006; 88: 1091-1098.
30. Ying QL, Stavridis M, Griffiths D, Li M, Smith A. Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat Biotechnol 2003; 21: 183-186.
31. Chung S, Shin BS, Hedlund E, Pruszak J, Ferree A, Kanq UJ et al. Genetic selection of sox1GFP-expressing neural precursors removes residual tumorigenic pluripotent stem cells and attenuates tumor formation after transplantation. J Neurochem 2006; 97: 1467-1480.
32. Ginis I, Luo Y, Miura T, Thies S, Brandenberger R, Gerecht-Nir S et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004; 269: 360-380.
33. Pfendler KC, Catuar CS, Meneses JJ, Pedersen RA. Overexpression of Nodal promotes differentiation of mouse embryonic stem cells into mesoderm and endoderm at the expense of neuroectoderm formation. Stem Cells Dev 2005; 14: 162-172.
34. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95-105.
35. Avitzour M, Diskin R, Raboy B, Askari N, Engelberg D, Livnah O. Intrinsically active variants of all human p38 isoforms. FEBS J 2007; 274: 963-975.
36. Palmqvist L, Glover CH, Hsu L, Lu M, Bossen B, Piret JM et al. Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 2005; 23: 663-680.
37. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C et al. Dissecting self-renewal in stem cells with RNA interference. Nature 2006; 442: 533-538.
38. Jones FS, Meech R. Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues. Bioessays 1999; 21: 372-376.
39. Greenway DJ, Street M, Jeffries A, Buckley NJ. RE1 silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells. Stem Cells 2007; 25 354-363.
40. Lu CC, Robertson FJ. Multiple roles for Nodal in the epiblast of the mouse embryo in the establishment of anterior-posterior patterning. Dev Biol 2004; 273: 149-159.
41. Ying QL, Nichols J, Chambers I, Smith A. BMP induction at ld proteins suppresses differentiation and sustains embryonic stem cell-renewal in collaboration with STAT3.
42. Yamane T, Dylla SJ, Muijtjens M, Weissman IL. Enforced Bcl-2 expression overrides serum and feeder cell requirements for mouse embryonic stem cell self-renewal. Proc Natl Acad Sci USA 2005; 102: 3312-3317.
43. Peddada S, Yasui DH, LaSalle JM. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome. Hum Mol Genet 2006; 15: 2003-2014.
44. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2: 647-656.
45. Zhang KZ, Westberg JA, Holtta E, Andersson LC. BCL2 regulates neural differentiation. Proc Natl Acad Sci USA 1996; 93: 4504-4508.
46. Suzuki A, Tsutomi Y. Bcl-2 accelerates the neuronal differentiation: New evidence approaching to the biofunction of bcl-2 in the neuronal system. Brain Res 1998; 801: 59-66.
47. Sato N, Sakuma C, Kato H, Milligan CE, Oppenheim RW, Yaginuma H. Bcl-2 rescues motoneurons from early cell death in the cervical spinal cord of the chicken embryo. J Neurobiol 2002; 53: 381-390.
48. Lowell S, Benchoua A, Heavey B, Smith AG. Notch promotes neural lineage entry by pluripotent embryonic stem cells. PLoS Biol 2006; 4 e121.
49. Sumantran VN, Brederlau A, Funa K. BMP-6 and retinoic acid synergistically differentiate the IMR-32 human neuroblastoma cells. Anticancer Res 2003; 23: 1297-1303.
50. Niizuma H, Nakamura Y, Ozaki T, Nakanishi H, Ohira M, Isogai E et al Bcl-2 is a key regulator for the retinoic acid-induced apoptotic cell death in neuroblastoma. Oncogene 2006; 25: 5046-5055.